Neuphoria Therapeutics Inc.
NEUP | NASDAQ
$3.05
$0.00 (0.00%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -13.45B | -386.69M | -374.93M | -378.73M | -369.63M | 5.83M | -9.71M | -14.44M | -22.19M | -19.5M | -15.22M | -13.1M | -4.55M | -4.55M | -4.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 662.96M | 662.89M | 662.89M | 662.89M | 662.89M | 662.95K | 752.69K | 829.39K | 922.8K | 757.12K | 501.94K | 259.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 351.53M | 163.91M | 163.93M | 163.86M | 163.77M | 173.22K | 180.29K | 977.45K | 1.16M | 1.05M | 1.02M | 207.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -3.33M | -1.52M | 457.07K | 2.03M | 566.44K | -158.48K | -675.12K | 428.57K | 176.47K | -278.92K | 264.64K | -225.82K | 318.13K | -3.02M | -3.18M | -3.18M | -3.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | 12.57B | 92.59M | 94.41M | 96.5M | 89.44M | -6.1M | -6.12M | -4.71M | -1.73M | -8.63M | -17.84M | -17.93M | -21.55M | -13.06M | -7.21M | -12.78M | -13.31M | -15.24M | -14.27M | -7.81M | -6.14M | -4.64M | -4.14M | -3.7M |
Deferred Income Tax | -139.14M | -468.54M | -468.5M | -468.43M | -468.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.95M | -4.69M | -3.02M | 1.78M | -817.01K | 87.63K | -972.73K | -955.74K | 1.05M | 2.06M | 7.01M | 7.32M | 6.52M | 57.95K | -3.2M | -3.2M | -3.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Cash Flow | -12.91M | 59.46M | 74.79M | 77.87M | 77.23M | 651.51K | -15.88M | -18.3M | -20.79M | -24.26M | -24.52M | -23.24M | -19.59M | -17.56M | -14.96M | -15.98M | -16.5M | -15.24M | -14.27M | -7.81M | -6.14M | -4.64M | -4.14M | -3.7M |
Capital Expenditures | n/a | -3 | -3 | -3 | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -772 | -772 | -772 | -772 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89.41K | -89.41K | -88.64K | -88.64K | 768.86 | 768.86 | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187.41K | 91.57K | 221.58K | 317.13K | 87.55K | 181.88K | 371.62K | 401.65K | 432.55K | 434.05K | 126.61K | 24.6K | 17.32K | -420.57K | -403.47K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187.41K | 91.57K | 221.58K | 317.13K | 87.55K | 181.88K | 371.62K | 401.65K | 343.15K | 344.64K | 37.97K | -64.04K | 18.09K | -419.8K | -403.47K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.28K | -52.14K | -80.55K | -119.78K | -94.5K | -67.64K | -66.43K | -71.69K | -6.13M | -7.48M | -8.41M | -8.37M | -2.83M | -2.73M | -3.2M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -810.36K | -810.36K | -810.36K | -810.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.35M | -5.86M | -5.52M | 1.5M | 1.27M | 4.77M | 4.91M | 13.07M | 4.48M | 236.1K | -2.1M | -10.87M | -2.05M | -2.96M | -1.34M | -2.45M | -3.3M | -3.26M | -3.04M | -1.13M | -314.97K | -203.02K | -174.11K | -25.72K |
Financial Cash Flow | 18.72M | 19.32M | 19.78M | 5.01M | 1.53M | 7.95M | 9.48M | 17.83M | 19.02M | 11.82M | 9.02M | 4.85M | 3.86M | 821.27K | 3.84M | 18.44M | 17.62M | 30.2M | 40.12M | 21.68M | 24.36M | 16.62M | 2.53M | 862.21K |
Net Cash Flow | 5.58M | 14.28B | 14.29B | 14.28B | 14.28B | 8.62M | -6.75M | -40.19K | -1.72M | -8.9M | -11.77M | -14.31M | -10.26M | -16.85M | -11.88M | 1.03M | -1.36M | 14.35M | 26.04M | 13.84M | 18.15M | 11.97M | -2.06M | -3.18M |
Free Cash Flow | -12.35B | 59.46M | 74.79M | 77.87M | 77.23M | 651.51K | -15.88M | -18.3M | -20.79M | -24.26M | -24.52M | -23.24M | -19.59M | -17.56M | -14.96M | -15.98M | -16.5M | -15.24M | -14.27M | -7.81M | -6.14M | -4.64M | -4.14M | -3.7M |
Adj. Free Cash Flow | -12.71B | -104.45M | -89.14M | -85.99M | -86.54M | 478.29K | -16.06M | -19.28M | -21.94M | -25.31M | -25.54M | -23.45M | -19.59M | -17.56M | -14.96M | -15.98M | -16.5M | -15.24M | -14.27M | -7.81M | -6.14M | -4.64M | -4.14M | -3.7M |
Maintenance CapEx | n/a | -3 | -3 | -3 | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -772 | -772 | -772 | -772 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -12.35B | 59.46M | 74.79M | 77.87M | 77.23M | 651.51K | -15.88M | -18.3M | -20.79M | -24.26M | -24.52M | -23.24M | -19.59M | -17.56M | -14.96M | -15.98M | -16.5M | -15.24M | -14.27M | -7.81M | -6.14M | -4.64M | -4.14M | -3.7M |
Add to Watchlist
Select watchlists to add or remove NEUP